$CBL
CBL & ASSOCIATES PROPERTIES INC

2023 Q2 Form 10-Q Financial Statement

#000095017023020575 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $129.9M $136.4M $140.1M
YoY Change -5.22% -2.67% 5.19%
Cost Of Revenue $45.98M $50.93M $48.35M
YoY Change 0.4% 5.34% -1.61%
Gross Profit $83.89M $85.43M $91.76M
YoY Change -8.04% -6.89% 9.17%
Gross Profit Margin 64.6% 62.65% 65.49%
Selling, General & Admin $16.16M $19.23M $18.07M
YoY Change -12.43% 6.39% 43.31%
% of Gross Profit 19.26% 22.51% 19.7%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $49.74M $53.27M $68.94M
YoY Change -22.85% -22.73% 43.3%
% of Gross Profit 59.3% 62.35% 75.14%
Operating Expenses $65.90M $72.50M $87.02M
YoY Change -20.53% -16.69% 43.3%
Operating Profit $17.99M $12.94M $4.740M
YoY Change 116.85% 172.89% -79.68%
Interest Expense $44.17M $43.52M $90.66M
YoY Change -19.86% -51.99% 275.71%
% of Operating Profit 245.54% 336.48% 1912.64%
Other Income/Expense, Net -$40.73M -$12.27M -$48.04M
YoY Change -20.27% -74.47% -1118.31%
Pretax Income -$22.44M $413.0K -$42.42M
YoY Change -49.31% -100.97% 54.1%
Income Tax $219.0K -$101.0K $801.0K
% Of Pretax Income -24.46%
Net Earnings -$20.79M $2.259M -$43.22M
YoY Change -49.77% -105.23% 61.5%
Net Earnings / Revenue -16.01% 1.66% -30.85%
Basic Earnings Per Share -$0.67 $0.06 -$1.45
Diluted Earnings Per Share -$0.67 $0.06 -$1.454M
COMMON SHARES
Basic Shares Outstanding 32.06M 32.06M 31.81M
Diluted Shares Outstanding 31.31K 31.37K 28.00K

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.92M $22.56M $185.7M
YoY Change -85.93% -87.86% 119.41%
Cash & Equivalents $24.92M $22.56M $185.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $34.76M $32.59M $21.82M
Other Receivables $3.318M $4.203M $5.356M
Total Short-Term Assets $63.00M $59.35M $212.9M
YoY Change -69.77% -72.13% 22.88%
LONG-TERM ASSETS
Property, Plant & Equipment $1.613B $1.631B $1.725B
YoY Change -5.1% -5.46% -49.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $74.14M $75.90M $250.7M
YoY Change -13.48% -69.72% -50.32%
Other Assets $88.67M $72.43M $59.42M
YoY Change 8.41% 21.91% -28.85%
Total Long-Term Assets $2.412B $2.456B $2.636B
YoY Change -5.99% -6.83% -35.81%
TOTAL ASSETS
Total Short-Term Assets $63.00M $59.35M $212.9M
Total Long-Term Assets $2.412B $2.456B $2.636B
Total Assets $2.475B $2.516B $2.849B
YoY Change -10.78% -11.71% -33.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $114.1M $110.1M $159.5M
YoY Change -22.07% -30.97% -14.1%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $114.1M $110.1M $159.5M
YoY Change -22.07% -30.97% -14.1%
LONG-TERM LIABILITIES
Long-Term Debt $1.942B $1.946B $2.035B
YoY Change -4.59% -4.36% 96.25%
Other Long-Term Liabilities $94.18M $101.6M $141.4M
YoY Change -28.18% -28.12% -94.46%
Total Long-Term Liabilities $2.036B $2.048B $2.176B
YoY Change -6.01% -5.9% -39.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $114.1M $110.1M $159.5M
Total Long-Term Liabilities $2.036B $2.048B $2.176B
Total Liabilities $2.150B $2.158B $2.339B
YoY Change -7.03% -7.71% -38.05%
SHAREHOLDERS EQUITY
Retained Earnings -$381.5M -$348.7M
YoY Change 57.9%
Common Stock $32.00K $32.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $334.0M $362.8M $510.8M
YoY Change
Total Liabilities & Shareholders Equity $2.475B $2.516B $2.849B
YoY Change -10.78% -11.71% -33.43%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$20.79M $2.259M -$43.22M
YoY Change -49.77% -105.23% 61.5%
Depreciation, Depletion And Amortization $49.74M $53.27M $68.94M
YoY Change -22.85% -22.73% 43.3%
Cash From Operating Activities $51.06M $33.18M $42.43M
YoY Change 11.83% -21.81% -32.4%
INVESTING ACTIVITIES
Capital Expenditures $10.74M $6.729M -$5.762M
YoY Change -220.65% -216.78% -16.07%
Acquisitions
YoY Change
Other Investing Activities $6.535M $710.0K $471.0K
YoY Change -53.42% 50.74% 29.4%
Cash From Investing Activities -$4.200M $29.87M -$2.442M
YoY Change -181.84% -1323.26% -4.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -28.26M -110.0M -31.03M
YoY Change -23.83% 254.58% 125.47%
NET CHANGE
Cash From Operating Activities 51.06M 33.18M 42.43M
Cash From Investing Activities -4.200M 29.87M -2.442M
Cash From Financing Activities -28.26M -110.0M -31.03M
Net Change In Cash 18.61M -46.96M 8.962M
YoY Change 35.83% -624.01% -80.7%
FREE CASH FLOW
Cash From Operating Activities $51.06M $33.18M $42.43M
Capital Expenditures $10.74M $6.729M -$5.762M
Free Cash Flow $40.33M $26.45M $48.19M
YoY Change -26.09% -45.12% -30.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000910612
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 cbl Debt Instrument Extended Maturity Date
DebtInstrumentExtendedMaturityDate
2024-05-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-12494
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CBL & ASSOCIATES PROPERTIES, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1545718
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2030 Hamilton Place Blvd.
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 500
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Chattanooga
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37421
CY2023Q1 dei City Area Code
CityAreaCode
423
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
855-0001
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value, with associated Stock Purchase Rights
CY2023Q1 dei Trading Symbol
TradingSymbol
CBL
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Bankruptcy Proceedings Reporting Current
EntityBankruptcyProceedingsReportingCurrent
true
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32060922
CY2023Q1 us-gaap Land
Land
590327000
CY2022Q4 us-gaap Land
Land
596715000
CY2023Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1194887000
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1198597000
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1785214000
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1795312000
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
161466000
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
136901000
CY2023Q1 cbl Real Estate Investment Property Net Before Development In Process
RealEstateInvestmentPropertyNetBeforeDevelopmentInProcess
1623748000
CY2022Q4 cbl Real Estate Investment Property Net Before Development In Process
RealEstateInvestmentPropertyNetBeforeDevelopmentInProcess
1658411000
CY2023Q1 us-gaap Development In Process
DevelopmentInProcess
7162000
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
5576000
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1630910000
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1663987000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22555000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44718000
CY2023Q1 cbl Restricted Cash And Escrow Deposit
RestrictedCashAndEscrowDeposit
72432000
CY2022Q4 cbl Restricted Cash And Escrow Deposit
RestrictedCashAndEscrowDeposit
97231000
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
259928000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
293476000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
259404000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
292422000
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
32590000
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
40620000
CY2023Q1 us-gaap Other Receivables
OtherReceivables
4203000
CY2022Q4 us-gaap Other Receivables
OtherReceivables
3876000
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
75900000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
77295000
CY2023Q1 us-gaap Finite Lived Intangible Asset Acquired In Place Leases
FiniteLivedIntangibleAssetAcquiredInPlaceLeases
219391000
CY2022Q4 us-gaap Finite Lived Intangible Asset Acquired In Place Leases
FiniteLivedIntangibleAssetAcquiredInPlaceLeases
247497000
CY2023Q1 cbl Finite Lived Intangible Asset Above Market Leases Net
FiniteLivedIntangibleAssetAboveMarketLeasesNet
156274000
CY2022Q4 cbl Finite Lived Intangible Asset Above Market Leases Net
FiniteLivedIntangibleAssetAboveMarketLeasesNet
171265000
CY2023Q1 cbl Intangible Lease And Other Assets
IntangibleLeaseAndOtherAssets
42132000
CY2022Q4 cbl Intangible Lease And Other Assets
IntangibleLeaseAndOtherAssets
39332000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2515791000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2678243000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1946429000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2000186000
CY2023Q1 us-gaap Below Market Lease Net
BelowMarketLeaseNet
101628000
CY2022Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
110616000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
110129000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
200312000
CY2023Q1 us-gaap Liabilities
Liabilities
2158186000
CY2022Q4 us-gaap Liabilities
Liabilities
2311114000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32060922
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32060922
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31780075
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31780075
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
32000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
32000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
711956000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
710497000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-524000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1054000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-348699000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-338934000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
362765000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
370541000
CY2023Q1 us-gaap Minority Interest
MinorityInterest
-5160000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-3412000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
357605000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
367129000
CY2023Q1 us-gaap Assets
Assets
2515791000
CY2022Q4 us-gaap Assets
Assets
2678243000
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
130324000
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
135332000
CY2023Q1 cbl Management Developmentand Leasing Fees Revenues
ManagementDevelopmentandLeasingFeesRevenues
2434000
CY2022Q1 cbl Management Developmentand Leasing Fees Revenues
ManagementDevelopmentandLeasingFeesRevenues
1769000
CY2023Q1 us-gaap Other Income
OtherIncome
3601000
CY2022Q1 us-gaap Other Income
OtherIncome
3001000
CY2023Q1 us-gaap Revenues
Revenues
136359000
CY2022Q1 us-gaap Revenues
Revenues
140102000
CY2023Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
24614000
CY2022Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
23344000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
53269000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
68943000
CY2023Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
14788000
CY2022Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
14435000
CY2023Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
11524000
CY2022Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
10566000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19229000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18074000
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
44000
CY2022Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
81000
CY2023Q1 us-gaap Other General Expense
OtherGeneralExpense
198000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
123578000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
135281000
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
2665000
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
155000
CY2023Q1 us-gaap Interest Expense
InterestExpense
43524000
CY2022Q1 us-gaap Interest Expense
InterestExpense
90659000
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
28151000
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
36250000
CY2023Q1 cbl Gains Losses On Sales Of Real Estate Asset
GainsLossesOnSalesOfRealEstateAsset
1596000
CY2022Q1 cbl Gains Losses On Sales Of Real Estate Asset
GainsLossesOnSalesOfRealEstateAsset
16000
CY2022Q1 us-gaap Reorganization Items
ReorganizationItems
1571000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-101000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
801000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1256000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8566000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12267000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-48044000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
514000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-43223000
CY2022Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
-15000
CY2023Q1 cbl Net Income Loss Attributable To Other Consolidated Subsidiaries
NetIncomeLossAttributableToOtherConsolidatedSubsidiaries
-1745000
CY2022Q1 cbl Net Income Loss Attributable To Other Consolidated Subsidiaries
NetIncomeLossAttributableToOtherConsolidatedSubsidiaries
-2486000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2259000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-40722000
CY2023Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
280000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1979000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40722000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.45
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.45
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31304
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27998
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31369
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27998
CY2023Q1 us-gaap Profit Loss
ProfitLoss
514000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-43223000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
530000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
42000
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1044000
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
43181000
CY2022Q1 cbl Operating Partnership Comprehensive Income Net Of Tax
OperatingPartnershipComprehensiveIncomeNetOfTax
15000
CY2023Q1 cbl Other Consolidated Subsidiaries Comprehensive Income Net Of Tax
OtherConsolidatedSubsidiariesComprehensiveIncomeNetOfTax
1745000
CY2022Q1 cbl Other Consolidated Subsidiaries Comprehensive Income Net Of Tax
OtherConsolidatedSubsidiariesComprehensiveIncomeNetOfTax
2486000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2789000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40680000
CY2023Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
280000
CY2023Q1 cbl Comprehensive Income Loss Attributable To Common Shareholders
ComprehensiveIncomeLossAttributableToCommonShareholders
2509000
CY2022Q1 cbl Comprehensive Income Loss Attributable To Common Shareholders
ComprehensiveIncomeLossAttributableToCommonShareholders
-40680000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
401100000
CY2022Q1 cbl Net Income Loss Excluding Amount Recognized In Temporary Equity
NetIncomeLossExcludingAmountRecognizedInTemporaryEquity
-43223000
CY2022Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
42000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2743000
CY2022Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
10982795
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
152538000
CY2022Q1 cbl Noncontrolling Interest Increase Decrease From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseDecreaseFromSubsidiaryEquityIssuance
143000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
513343000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
367129000
CY2023Q1 cbl Net Income Loss Excluding Amount Recognized In Temporary Equity
NetIncomeLossExcludingAmountRecognizedInTemporaryEquity
514000
CY2023Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
530000
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
12024000
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
152905
CY2023Q1 cbl Issuance Of Common Stock Associated With Performance Stock Units Net Of Shares Withheld For Tax Shares
IssuanceOfCommonStockAssociatedWithPerformanceStockUnitsNetOfSharesWithheldForTaxShares
133221
CY2023Q1 cbl Issuance Of Common Stock Associated With Performance Stock Units Net Of Shares Withheld For Tax
IssuanceOfCommonStockAssociatedWithPerformanceStockUnitsNetOfSharesWithheldForTax
-1793000
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
3000
CY2023Q1 cbl Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
1843000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
1409000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
357605000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
514000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-43223000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53269000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
68943000
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7852000
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
63655000
CY2023Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
5337000
CY2022Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
6323000
CY2023Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
1596000
CY2022Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
16000
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
28151000
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
36250000
CY2023Q1 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
17000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3252000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2743000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1256000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8566000
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3335000
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
7840000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-138000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-737000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
225000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-67000
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-7934000
CY2022Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-3305000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2667000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5114000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-17264000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-16407000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33175000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42429000
CY2023Q1 cbl Payments To Additions To Real Estate Assets
PaymentsToAdditionsToRealEstateAssets
6729000
CY2022Q1 cbl Payments To Additions To Real Estate Assets
PaymentsToAdditionsToRealEstateAssets
5762000
CY2023Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
4622000
CY2022Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
16000
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
15004000
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
149936000
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
50850000
CY2022Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
149998000
CY2023Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
21000
CY2022Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
13000
CY2023Q1 cbl Investments In And Advancesto Subsidiariesand Affiliates
InvestmentsInAndAdvancestoSubsidiariesandAffiliates
4682000
CY2022Q1 cbl Investments In And Advancesto Subsidiariesand Affiliates
InvestmentsInAndAdvancestoSubsidiariesandAffiliates
997000
CY2023Q1 cbl Distributions In Excess Of Equity In Earnings Of Unconsolidated Affiliates
DistributionsInExcessOfEquityInEarningsOfUnconsolidatedAffiliates
1504000
CY2022Q1 cbl Distributions In Excess Of Equity In Earnings Of Unconsolidated Affiliates
DistributionsInExcessOfEquityInEarningsOfUnconsolidatedAffiliates
4697000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
710000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
471000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
29872000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2442000
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
26155000
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
29500000
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1668000
CY2022Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
143000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1793000
CY2023Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
3000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
82058000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-110009000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-31025000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46962000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8962000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141949000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
236198000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94987000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
245160000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22555000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
185744000
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
35006000
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
28678000
CY2023Q1 us-gaap Escrow Deposit
EscrowDeposit
37426000
CY2022Q1 us-gaap Escrow Deposit
EscrowDeposit
30738000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94987000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
245160000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
32762000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
21453000
CY2022Q1 cbl Cash Paid For Reorganization Items
CashPaidForReorganizationItems
3156000
CY2023Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
22
CY2023Q1 cbl Number Of Regional Malls Open Air Centers Owned
NumberOfRegionalMallsOpenAirCentersOwned
47
CY2023Q1 cbl Number Of Outlet Centers Owned
NumberOfOutletCentersOwned
5
CY2023Q1 cbl Number Of Lifestyle Centers Owned
NumberOfLifestyleCentersOwned
5
CY2023Q1 cbl Number Of Open Air Centers Owned
NumberOfOpenAirCentersOwned
29
CY2023Q1 cbl Number Of Other Properties Owned
NumberOfOtherPropertiesOwned
5
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
91
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
97231000
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
130324000
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
135332000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5295000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3943000
CY2023Q1 us-gaap Revenues
Revenues
136359000
CY2022Q1 us-gaap Revenues
Revenues
140102000
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
85426000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P5Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P5Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P20Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
20836000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
46953000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
42213000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
110002000
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
98981000
CY2022Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
95648000
CY2023Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
31343000
CY2022Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
39684000
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
130324000
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
135332000
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
316868000
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
310620000
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
242066000
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
182356000
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
131418000
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
209673000
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
1478427000
CY2023Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1770334000
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1833992000
CY2023Q1 cbl Number Of Entities Equity Method Of Accounting
NumberOfEntitiesEquityMethodOfAccounting
24
CY2023Q1 cbl Numberof Joint Venture Entities
NumberofJointVentureEntities
16
CY2023Q1 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
972999000
CY2022Q4 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
1023634000
CY2023Q1 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
1052704000
CY2022Q4 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
1065942000
CY2023Q1 cbl Long Term Debt Net Excluding Deferred Financing Costs
LongTermDebtNetExcludingDeferredFinancingCosts
2025703000
CY2023Q1 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0650
CY2022Q4 cbl Long Term Debt Net Excluding Deferred Financing Costs
LongTermDebtNetExcludingDeferredFinancingCosts
2089576000
CY2022Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0621
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
15903000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
17101000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
63371000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
72289000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1946429000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2000186000
CY2023Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0425
CY2023Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
125534000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
180237000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
188860000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
828607000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
375588000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
360895000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
950000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
61905000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1997042000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
180237000
CY2023Q1 us-gaap Revenues
Revenues
136359000
CY2023Q1 cbl Property Operating Expenses
PropertyOperatingExpenses
50926000
CY2023Q1 us-gaap Interest Expense
InterestExpense
43524000
CY2023Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1596000
CY2023Q1 us-gaap Other General Expense
OtherGeneralExpense
198000
CY2023Q1 cbl Segment Profit Loss
SegmentProfitLoss
43307000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
53269000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19229000
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
44000
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
2665000
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
28151000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-101000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1256000
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
514000
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
7535000
CY2022Q1 us-gaap Revenues
Revenues
140102000
CY2022Q1 cbl Property Operating Expenses
PropertyOperatingExpenses
48345000
CY2022Q1 us-gaap Interest Expense
InterestExpense
90659000
CY2022Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
16000
CY2022Q1 cbl Segment Profit Loss
SegmentProfitLoss
1114000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
68943000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18074000
CY2022Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
81000
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
155000
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
36250000
CY2022Q1 us-gaap Reorganization Items
ReorganizationItems
1571000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
801000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8566000
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-43223000
CY2022Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
5830000
CY2023Q1 us-gaap Assets
Assets
2515791000
CY2022Q4 us-gaap Assets
Assets
2678243000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2259000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-40722000
CY2023Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
280000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1979000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40722000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31304
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27998
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.45
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1979000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-40722000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31369
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27998
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.45
CY2023Q1 cbl Environmental Liability Insurance Maximum Coverage Per Incident
EnvironmentalLiabilityInsuranceMaximumCoveragePerIncident
40000000
CY2023Q1 cbl Environmental Liability Insurance Maximum Coverage Amount
EnvironmentalLiabilityInsuranceMaximumCoverageAmount
40000000
CY2023Q1 us-gaap Guarantees Fair Value Disclosure
GuaranteesFairValueDisclosure
556000
CY2022Q4 us-gaap Guarantees Fair Value Disclosure
GuaranteesFairValueDisclosure
561000
CY2023Q1 cbl Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValueGranted
6120000
CY2023Q1 cbl Additions To Real Estate Assets Accrued But Not Yet Paid
AdditionsToRealEstateAssetsAccruedButNotYetPaid
9632000
CY2022Q1 cbl Additions To Real Estate Assets Accrued But Not Yet Paid
AdditionsToRealEstateAssetsAccruedButNotYetPaid
11177000

Files In Submission

Name View Source Status
0000950170-23-020575-index-headers.html Edgar Link pending
0000950170-23-020575-index.html Edgar Link pending
0000950170-23-020575.txt Edgar Link pending
0000950170-23-020575-xbrl.zip Edgar Link pending
cbl-20230331.htm Edgar Link pending
cbl-20230331.xsd Edgar Link pending
cbl-ex31_1.htm Edgar Link pending
cbl-ex31_2.htm Edgar Link pending
cbl-ex32_1.htm Edgar Link pending
cbl-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
cbl-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cbl-20230331_cal.xml Edgar Link unprocessable
cbl-20230331_pre.xml Edgar Link unprocessable
cbl-20230331_lab.xml Edgar Link unprocessable
cbl-20230331_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending